MD Abolghasem Rezaei Faces DEA Registration Enforcement Action
Published Date: 10/20/2025
Notice
Summary
Dr. Abolghasem Rezaei from Oklahoma lost his DEA registration because he no longer has the state permission to handle controlled substances. Since he didn’t ask for a hearing, the DEA canceled his registration by default, meaning he can’t legally prescribe or manage these drugs anymore. This change is effective immediately and impacts Dr. Rezaei’s ability to work with controlled substances.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Oklahoma Doctor
The DEA revoked Dr. Abolghasem Rezaei's Certificate of Registration No. FR0228747, effective November 19, 2025. Because his Oklahoma Bureau of Narcotics and Dangerous Drugs Control (OBNDD) registration is inactive (suspended December 5, 2024 and upheld February 13, 2025), he cannot lawfully prescribe, administer, dispense, or handle controlled substances in Oklahoma.
Pending and New DEA Applications Denied
The DEA also denied any pending applications of Abolghasem Rezaei, M.D., to renew or modify Certificate of Registration No. FR0228747, and denied any other pending application for additional DEA registration in Oklahoma; this denial is effective November 19, 2025.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in